January 18, 2018 / 9:25 PM / 3 months ago

BRIEF-Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility

Reuters Staff

1 Min Read

Jan 18 (Reuters) - Cellular Biomedicine Group Inc:

* CELLULAR BIOMEDICINE GROUP INC - ANNOUNCED PLAN TO CONFIGURE PART OF ITS FACILITY IN SHANGHAI WITH GE HEALTHCARE’S FLEXFACTORY PLATFORM

* CELLULAR BIOMEDICINE-AFTER EXECUTION OF NON-BINDING LOI, SEES FLEXFACTORY TO BE OPERATIONAL IN CBMG-GE JOINT LABORATORY OF CELL THERAPY BY END OF 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.